Search Ontology:
ChEBI
lividomycin A
- Term ID
- CHEBI:71961
- Synonyms
-
- (1R,2R,3S,4R,6S)-4,6-diamino-3-hydroxy-2-{[alpha-D-mannopyranosyl-(1->4)-2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl-(1->3)-beta-D-ribofuranosyl]oxy}cyclohexyl 2-amino-2,3-dideoxy-alpha-D-ribo-hexopyranoside
- antibiotic 503-2
- antibiotic SF 767 A
- lividomicina
- lividomycin
- lividomycine
- lividomycinum
- mannosyldeoxyparomomycin
- O-2-amino-2,3-dideoxy-alpha-D-ribo-hexopyranosyl-(1-4)-O-(O-alpha-D-mannopyranosyl-(1-4)-O-2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl-(1-3)-beta-D-ribofuranosyl-(1-5))-2-deoxy-D-streptamine
- quintomycin B
- SF 767 A
- Definition
- A member of the class of lividomycins that is lividomycin B in which position 4 of the diamino-L-idopyranosyl moiety has been converted into its α-D-mannopyranoside.
- References
-
- cas:36441-41-5
- drugbank:DB04728
- kegg.compound:C17707
- metacyc.compound:CPD-14175
- pdb-ccd:LIV
- pubmed:1047630
- pubmed:1052072
- pubmed:4142798
- pubmed:4203572
- pubmed:4215906
- pubmed:4364938
- pubmed:4945812
- pubmed:5034809
- pubmed:5092786
- pubmed:779697
- reaxys:6763509
- wikipedia.en:Lividomycin
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from lividomycin A
Phenotype where environments contain lividomycin A
Phenotype modified by environments containing lividomycin A
Phenotype affecting lividomycin A
Human Disease Model